FDA Device Intelligence
Home › ILLUMINA, INC. › NextSeq 550Dx Sequencing System

NextSeq 550Dx Sequencing System

ILLUMINA, INC. · Model 20005715 · UDI-DI 00816270020125

PFF Prescription
2
510(k) clearances
8
Adverse events
12
Recalls
11
Facilities

Description

The Illumina NextSeq 550Dx instrument is intended for sequencing DNA libraries prepared by adding sample indices and capture sequences to amplified targets. These libraries are captured on a flow cell and sequenced on the instrument using sequencing by synthesis (SBS) chemistry. SBS chemistry uses a reversible-terminator method to detect single nucleotide bases incorporated into growing DNA strands. Instrument software performs image analysis and base calling, assigning a quality score to each base for each sequencing cycle. When primary analysis finishes, secondary analysis processes base calls on the instrument. The NextSeq 550Dx instrument uses different secondary analysis modules depending on the workflow. For the germline or somatic variant calling modules, data processing includes de-multiplexing, FASTQ file generation, alignment, variant calling, and generation of variant call format (VCF) files containing information regarding variants found at specific positions in a reference genome.

Recalls

DateFirmReason
2024-09-17Illumina, Inc.Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server wit
2024-02-07Life Technologies CorporationTorrent Suite Dx Software versions 5.14 and earlier used in connection with Ion PGM DX Systems exploitation of the vulnerability by a threat actor may allow them to alter settings,
2023-04-05Illumina, Inc.Cybersecurity vulnerability concerning the software used for sequencing instruments.
2023-04-05Illumina, Inc.Cybersecurity vulnerability concerning the software used for sequencing instruments.
2022-05-03Illumina, Inc.cybersecurity vulnerability
2022-05-03Illumina, Inc.cybersecurity vulnerability
2022-02-22Illumina, Inc.There is a potential that the DNA sequence analyzer may short circuit shortly after disconnection and reconnection of circuit board or imaging module due to an insufficient reconn
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.